We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Innovative Guidewire Advances Coronary Procedures

By HospiMedica International staff writers
Posted on 04 May 2010
A new guidewire equipped with a uniquely designed nickel-titanium (nitinol) sleeve offers significantly improved torque control, compared to conventional spring coil guidewires. More...


The Kinetix Guidewire is intended for use in percutaneous coronary interventions (PCIs), and is designed to deliver enhanced responsiveness and maneuverability in the placement of balloon dilatation catheters or other interventional therapeutic devices during percutaneous trans-luminal cardiac angioplasty (PTCA), percutaneous trans-luminal angioplasty (PTA), or other intravascular procedures. The microcut nitinol sleeve and a nitinol distal core are designed to provide more efficient energy transfer from the physicians hand to the soft distal-tip guide wire tip, resulting in an increased torque transmission and flexibility and an improved turn-for-turn torque response. The Kinetix Guidewire is a product of Boston Scientific (Natick, MA, USA), and is based on the company's Synchro guidewires, used in neurovascular interventions.

"The Kinetix Guidewire provided exceptional torque and flexibility,” said Joseph DeGregorio, M.D., of the Hackensack University Medical Center (NJ, USA), who conducted the first PCI procedure worldwide of the new guidewire. "It's rare to find a workhorse guidewire that combines outstanding deliverability of the wire, support for device deliverability and an excellent safety profile.”

"We're pleased to begin offering this innovative technology that should help physicians simplify coronary angioplasty procedures,” said Hank Kucheman, executive vice president of Boston Scientific, and president of the cardiology, rhythm, and vascular group. "Kinetix reinforces our commitment to providing improved treatment options that promote better patient outcomes.”

Related Links:
Boston Scientific



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Fetal Monitor
BT-380
New
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.